ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Cesium carbonate → 1-[2-({3-Methyl-5-[2-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,3-thiazol-5-yl]phenyl}amino)pyrimidin-4-yl]ethanone

HRID 1040136
印刷

反応式

HRID 1040136 の反応式
[NH2:1][C:2]1[CH:3]=[C:4]([C:9]2[S:13][C:12]([C:14]([OH:20])([CH3:19])[C:15]([F:18])([F:17])[F:16])=[N:11][CH:10]=2)[CH:5]=[C:6]([CH3:8])[CH:7]=1.C(=O)([O-])[O-].[Cs+].[Cs+].Cl[C:28]1[N:33]=[C:32]([C:34](=[O:36])[CH3:35])[CH:31]=[CH:30][N:29]=1.CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2>CC([O-])=O.CC([O-])=O.[Pd+2].O1CCOCC1>[CH3:8][C:6]1[CH:7]=[C:2]([NH:1][C:28]2[N:33]=[C:32]([C:34](=[O:36])[CH3:35])[CH:31]=[CH:30][N:29]=2)[CH:3]=[C:4]([C:9]2[S:13][C:12]([C:14]([OH:20])([CH3:19])[C:15]([F:18])([F:17])[F:16])=[N:11][CH:10]=2)[CH:5]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 10796Cesium carbonateHCID 6360441,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 446138781-(2-Chloropyrimidin-4-yl)ethanoneHCID 584561172-[5-(3-Amino-5-methylphenyl)-1,3-thiazol-2-yl]-1,1,1-trifluoropropan-2-ol

生成物 1

HCID 584563541-[2-({3-Methyl-5-[2-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,3-thiazol-5-yl]phenyl}amino)pyrimidin-4-yl]ethanone
収率 36%

試薬・触媒・溶媒 2

HCID 167845palladium(II) acetate触媒HCID 312751,4-Dioxane溶媒

反応条件

温度
100 °C

実験手順

To Intermediate 17 (500 mg, 1.654 mmol) in a scintillation vial was added dioxane (8.27 mL), cesium carbonate (1078 mg, 3.31 mmol), and 1-(2-chloropyrimidin-4-yl)ethanone (285 mg, 1.819 mmol). The system was purged and flushed with Ar(g) three times before adding Xantphos (144 mg, 0.248 mmol) and Pd(OAc)2 (40.8 mg, 0.182 mmol). The system was purged and flushed with Ar(g) three times before sealing the system and heating to 100° C. The reaction was stirred overnight and was cooled to room temperature. The reaction mixture was filtered through celite (washed with chloroform) and diluted with water. The organic layer was separated, dried over sodium sulfate, and was concentrated to dryness before purification by column chromatography (10-40% acetone in hexanes, linear gradient) to yield 1-[2-({3-methyl-5-[2-(1,1,1-trifluoro-2-hydroxypropan-2-yl)-1,3-thiazol-5-yl]phenyl}amino)pyrimidin-4-yl]ethanone (250 mg, 0.592 mmol, 36%). MS ESI: [M+H]+ m/z 423.1. 1H NMR (500 MHz, CDCl3) δ 8.66 (d, J=4.9, 1H), 7.95 (s, 2H), 7.34 (dd, J=8.1, 13.0, 3H), 7.10 (s, 1H), 2.73 (s, 3H), 2.42 (s, 3H), 1.85 (s, 3H). rhSYK activity=+++

後処理

  1. customThe system was purged
  2. customflushed with Ar(g) three times
  3. customThe system was purged
  4. customflushed with Ar(g) three times
  5. temperaturewas cooled to room temperature
  6. filtrationThe reaction mixture was filtered through celite (washed with chloroform)
  7. additiondiluted with water
  8. customThe organic layer was separated
  9. dry with materialdried over sodium sulfate
  10. concentrationwas concentrated to dryness before purification by column chromatography (10-40% acetone in hexanes, linear gradient)

出典と根拠

ORDレコード
ord-a573cf4a16cf4a9ea7ee75fccbbc8e1c
出典データセット
uspto-grants-2013_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08551984B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート